RELENTLESS AS
Keywords
researchdevelopment workbiotechnologygenomicspharmageneticsgene samplesdna sequencingdna synthesisdna deepeninggenetic engineeringproteinsmoleculespeptide sequencinglipidglycotechniqueproteomicshormonesgrowth factorscell receptorspheromonescell culturetissue culturecrossingcell fusionvaccineimmunostimulatorsembryo manipulationprocess biotechnologybioreactorsfermentationbioprocessingbiorecoverybiodesulfurizationbiological pulp productionbiofiltrationbiological regenerationsubcellular organismsgene therapyvirusesvectors
Organization
- CEO
- AH
Andreas Holmen1979
- Chairman of the board
- MF
Maria Fjeld1998
- Years since formation
- 0 years
- since Feb 13, 2024
- Type
- Limited company
- VAT registered
- No
- Number of employees
- 0
Last update: Nov 23, 2024
Management
Management / administration
| Name | Role | Shares |
|---|---|---|
AH 1979 | Managing Director/CEO | - |
Board
| Name | Role | Shares |
|---|---|---|
AH 1979 | Board Member | - |
MF 1998 | Chairman | - |
ØT | Board Member | - |
Others
| Name | Role | Shares |
|---|---|---|
| Accountant | - |
Last update: Nov 23, 2024
Ownership
No available data
Financials
in NOK
No available data
Classification
Type of organization
Limited company
Classification of institutional sector
INNL
Domestic sectors
A_IKKE-FIN
Non-financial corporations
2100
Private non-financial incorporated enterprises
Standard industrial classification
M
Main industrial area
Professional, scientific and technical activities
72
Activity
Scientific research and development
72.1
Main industrial group
Research and experimental development on natural sciences and engineering
72.11
Industrial group
Research and experimental development on biotechnology
72.110
Industrial group
Research and experimental development on biotechnology